cyclosporine
Showing 1 - 25 of 1,620
Dry Eye Disease Trial in Waterloo (0.09% cyclosporine A ophthalmic solution)
Recruiting
- Dry Eye Disease
- 0.09% cyclosporine A ophthalmic solution
-
Waterloo, Ontario, CanadaUniversity of Waterloo
Jul 13, 2023
The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese
Active, not recruiting
- The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects
- Mindeudesivir hydrobromide tablets and Clarithromycin tablets
- Mindeudesivir hydrobromide tablets and Cyclosporine softgels
-
Zhengzhou, Henan, ChinaZhengzhou Sixth People's Hospital
Aug 15, 2023
Clinical Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis Trial in Al Farwaniyah (cyclosporine A 0.05% eye drops)
Recruiting
- Clinical Outcomes of Cyclosporine Eye Drops in Herpetic Keratitis
- cyclosporine A 0.05% eye drops
-
Al Farwānīyah, Farwanyia, KuwaitFarwanyia Hospital
Jan 31, 2023
Nephrotic Syndrome Trial in Alexandria (Cyclosporine Capsule)
Recruiting
- Nephrotic Syndrome
- Cyclosporine Capsule
-
Alexandria, EgyptAlexandria University
Jan 21, 2023
Pterygium Trial in Menoufia (Mitomycin c)
Completed
- Pterygium
- Mitomycin c
-
Menoufia, EgyptFaculty of Medicine, Menoufia University
Nov 16, 2022
Dry Eye Trial in Beijing (artificial tear eyedrops, 0.05% cyclosporine eyedrops)
Recruiting
- Dry Eye
- artificial tear eyedrops
- 0.05% cyclosporine eyedrops
-
Beijing, Beijing, ChinaHong Qi
Sep 12, 2023
Nephrotic Syndrome, Proteinuria, Autoimmune Disease Trial run by the NIDDK (Rituximab Infusion, Oral Cyclosporine)
Recruiting
- Nephrotic Syndrome
- +4 more
- Rituximab Infusion
- Oral Cyclosporine
-
Bethesda, Maryland
- +1 more
Jan 25, 2023
Healthy Trial in New Haven (PF-07081532, Cyclosporine, Itraconazole)
Recruiting
- Healthy
- PF-07081532
- +2 more
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Mar 2, 2023
Healthy Trial in Singapore (Midazolam, LY3502970, Cyclosporine)
Recruiting
- Healthy
- Midazolam
- +2 more
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Nov 23, 2022
Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)
Recruiting
- Severe Aplastic Anemia
- Eltrombopag
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Idiopathic Membranous Nephropathy Trial in Beijing (Rituximab, Modified Ponticelli regimen)
Recruiting
- Idiopathic Membranous Nephropathy
- Rituximab
- Modified Ponticelli regimen
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 23, 2023
Non Severe Aplastic Anemia, Untreated Trial in China (Herombopag)
Recruiting
- Non Severe Aplastic Anemia
- Untreated
-
Tangshan, Hebei, China
- +3 more
Dec 14, 2022
Steroid Dependent and Frequent Relapsing Nephrotic Syndrome in
Not yet recruiting
- Steroid Dependent and Frequent Relapsing Nephrotic Syndrome
- observation of the adverse outcomes of Cyclosporine in steroid dependent and frequent relapsing nephrotic syndrome in children
-
Sohag, EgyptSohag University Hospital
Oct 17, 2022
Vernal Keratoconjunctivitis, Cyclosporine 0.05% Eye Drops Trial in Nanchang (Cyclosporine 0.05% eye drops, Loteprednol Etabonate
Completed
- Vernal Keratoconjunctivitis
- Cyclosporine 0.05% Eye Drops
- Cyclosporine 0.05% eye drops
- Loteprednol Etabonate 0.5% and Tobramycin Eye Drops 0.3%
-
Nanchang, Jiangxi, Chinathe Second Affiliated Hospital of Nanchang University
Apr 28, 2022
DRESS Syndrome, Drug-Induced Hypersensitivity Syndrome Trial in Los Angeles (Cyclosporine, Methylprednisolone and Prednisone)
Enrolling by invitation
- DRESS Syndrome
- Drug-Induced Hypersensitivity Syndrome
- Cyclosporine
- Methylprednisolone and Prednisone
-
Los Angeles, CaliforniaUSC
May 7, 2022
Myocardial Injury, Cardiac Surgery Trial in Jakarta (Cyclosporin, remote ischemic preconditioning, Placebo)
Completed
- Myocardial Injury
- Cardiac Surgery
- Cyclosporin
- +2 more
-
Jakarta, DKI Jakarta, IndonesiaIndonesia University
Jan 10, 2023
Graft-versus-host-disease, Relapse Trial in Calgary (Treatment Arm - high dose ATG, Control Arm - standard of care)
Recruiting
- Graft-versus-host-disease
- Relapse
- Treatment Arm - high dose ATG
- Control Arm - standard of care
-
Calgary, Alberta, CanadaTom Baker Cancer Centre
Oct 14, 2022
Stability of Tacrolimus, Cyclosporine A, Everolimus and
Completed
- Transplantation Drugs Stability
- Blood sampling
-
Turin, ItalyAOU Città della Salute e della Scienza di Torino/S.C Biochimica
Oct 6, 2022
Dry Eye Trial in Hemet, Laguna Hills, Brecksville (Klarity CL, Cylcosporine 0.1%/Loteprednol Etabonate 0.2% Preservative Free)
Completed
- Dry Eye
- Klarity CL, Cylcosporine 0.1%/Loteprednol Etabonate 0.2% Preservative Free
-
Hemet, California
- +2 more
Dec 30, 2022
Dry Eye Syndromes Trial in Korea, Republic of (SCAI-001 0.01% eyedrop, SCAI-001 0.02% eyedrop, Restasis 0.05% eyedrop)
Recruiting
- Dry Eye Syndromes
- SCAI-001 0.01% eyedrop
- +2 more
-
Bucheon, Korea, Republic of
- +10 more
Feb 21, 2023
Ulcerative Colitis Acute Trial (Cyclosporine A)
Completed
- Ulcerative Colitis Acute
- Cyclosporine A
- (no location specified)
Jan 21, 2022
Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)
Not yet recruiting
- Primary Membranous Nephropathy
- MIL62
- Cyclosporine
- (no location specified)
May 16, 2023
Ulcerative Colitis Acute Trial in Ann Arbor (Cyclosporine Injection (IV), Cyclosporine Oral Product, Upadacitinib Extended
Not yet recruiting
- Ulcerative Colitis Acute
- Cyclosporine Injection (IV)
- +4 more
-
Ann Arbor, MichiganUniversity of Michigan
May 6, 2023